These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 11051241
21. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA. Cancer Res; 1997 Dec 01; 57(23):5221-5. PubMed ID: 9393738 [Abstract] [Full Text] [Related]
22. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française. Zhou XP, Sanson M, Hoang-Xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre JY, Thomas G, Hamelin R. Ann Neurol; 1999 Dec 01; 46(6):913-6. PubMed ID: 10589545 [Abstract] [Full Text] [Related]
23. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB. Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439 [Abstract] [Full Text] [Related]
24. [Mutations of p53 gene in 41 cases of human brain gliomas]. Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC. Ai Zheng; 2008 Jan 15; 27(1):8-11. PubMed ID: 18184456 [Abstract] [Full Text] [Related]
25. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. Cancer Res; 1997 Oct 01; 57(19):4187-90. PubMed ID: 9331072 [Abstract] [Full Text] [Related]
26. Genetic analysis of a multifocal glioblastoma multiforme: a suitable tool to gain new aspects in glioma development. Krex D, Mohr B, Appelt H, Schackert HK, Schackert G. Neurosurgery; 2003 Dec 01; 53(6):1377-84; discussion 1384. PubMed ID: 14633303 [Abstract] [Full Text] [Related]
27. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. Cheng Y, Pang JC, Ng HK, Ding M, Zhang SF, Zheng J, Liu DG, Poon WS. Histopathology; 2000 Nov 01; 37(5):437-44. PubMed ID: 11119125 [Abstract] [Full Text] [Related]
28. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255 [Abstract] [Full Text] [Related]
29. Molecular genetics of radiographically defined de novo glioblastoma multiforme. Tortosa A, Ino Y, Odell N, Swilley S, Sasaki H, Louis DN, Henson JW. Neuropathol Appl Neurobiol; 2000 Dec 01; 26(6):544-52. PubMed ID: 11123721 [Abstract] [Full Text] [Related]
30. Genetic profile of the giant cell glioblastoma. Peraud A, Watanabe K, Schwechheimer K, Yonekawa Y, Kleihues P, Ohgaki H. Lab Invest; 1999 Feb 01; 79(2):123-9. PubMed ID: 10068201 [Abstract] [Full Text] [Related]
31. Somatic mutations of PTEN in glioblastoma multiforme. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071 [Abstract] [Full Text] [Related]
32. PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis. Izumoto S, Ohnishi T, Kanemura H, Arita N, Maruno M, Moriuchi T, Suzuki S, Yoshimine T. J Neurooncol; 2001 May 01; 53(1):21-6. PubMed ID: 11678426 [Abstract] [Full Text] [Related]
33. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
34. p53 and PTEN gene mutations in gemistocytic astrocytomas. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H. Acta Neuropathol; 1998 Jun 01; 95(6):559-64. PubMed ID: 9650746 [Abstract] [Full Text] [Related]
35. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases. Hahn M, Wieland I, Koufaki ON, Görgens H, Sobottka SB, Schackert G, Schackert HK. Clin Cancer Res; 1999 Sep 01; 5(9):2431-7. PubMed ID: 10499615 [Abstract] [Full Text] [Related]
36. Influence of p53 mutations on prognosis of patients with glioblastoma. Shiraishi S, Tada K, Nakamura H, Makino K, Kochi M, Saya H, Kuratsu J, Ushio Y. Cancer; 2002 Jul 15; 95(2):249-57. PubMed ID: 12124823 [Abstract] [Full Text] [Related]
37. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas. Fan X, Muñoz J, Sanko SG, Castresana JS. Int J Oncol; 2002 Sep 15; 21(3):667-74. PubMed ID: 12168116 [Abstract] [Full Text] [Related]
38. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T. Int J Cancer; 2000 Jan 15; 85(2):160-5. PubMed ID: 10629071 [Abstract] [Full Text] [Related]
39. Somatic mutation of PTEN in bladder carcinoma. Aveyard JS, Skilleter A, Habuchi T, Knowles MA. Br J Cancer; 1999 May 15; 80(5-6):904-8. PubMed ID: 10360673 [Abstract] [Full Text] [Related]
40. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma. Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG. Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]